Microbot Medical Inc.
MBOT
$4.09
$0.20545.29%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | -34.56% | 23.32% | -5.51% | -30.43% | -3.96% |
Total Depreciation and Amortization | -20.00% | -42.31% | 13.04% | 64.29% | -50.00% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -53.91% | -9.54% | 0.71% | -15.11% | -26.93% |
Change in Net Operating Assets | 246.51% | -139.08% | 815.79% | -6.75% | 130.75% |
Cash from Operations | 10.47% | -69.96% | 38.71% | -40.98% | 19.13% |
Capital Expenditure | 30.77% | -85.71% | -- | 100.00% | 71.43% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 94.76% | -1,752.26% | 972.86% | -88.24% | 193.70% |
Cash from Investing | 94.73% | -1,760.87% | 967.86% | -88.20% | 192.37% |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | -82.91% | 881.85% | 347.39% | -69.48% | -13.48% |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | -82.91% | 881.85% | 347.39% | -69.48% | -13.48% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 752.94% | -96.13% | 232.73% | -252.42% | 199.69% |